Veena John

Clinical trials

• Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  Site PI · Recruiting · Phase 3

  National Cancer Institute (NCI)

  2026–2028
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  Site PI · Recruiting · Phase 3

  Eli Lilly and Company

  2025–2031
• A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

  Site PI · Recruiting · Phase 2

  GlaxoSmithKline

  2021–2026
• Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

  Site PI · Unknown · Phase 3

  Gynecologic Oncology Group

  2012